136 related articles for article (PubMed ID: 36001550)
1. Multimodality imaging and transcriptomics to phenotype mitral valve dystrophy in a unique knock-in Filamin-A rat model.
Delwarde C; Toquet C; Aumond P; Kayvanjoo AH; Foucal A; Le Vely B; Baudic M; Lauzier B; Blandin S; Véziers J; Paul-Gilloteaux P; Lecointe S; Baron E; Massaiu I; Poggio P; Rémy S; Anegon I; Le Marec H; Monassier L; Schott JJ; Mass E; Barc J; Le Tourneau T; Merot J; Capoulade R
Cardiovasc Res; 2023 May; 119(3):759-771. PubMed ID: 36001550
[TBL] [Abstract][Full Text] [Related]
2. New insights into mitral valve dystrophy: a Filamin-A genotype-phenotype and outcome study.
Le Tourneau T; Le Scouarnec S; Cueff C; Bernstein D; Aalberts JJJ; Lecointe S; Mérot J; Bernstein JA; Oomen T; Dina C; Karakachoff M; Desal H; Al Habash O; Delling FN; Capoulade R; Suurmeijer AJH; Milan D; Norris RA; Markwald R; Aikawa E; Slaugenhaupt SA; Jeunemaitre X; Hagège A; Roussel JC; Trochu JN; Levine RA; Kyndt F; Probst V; Le Marec H; Schott JJ
Eur Heart J; 2018 Apr; 39(15):1269-1277. PubMed ID: 29020406
[TBL] [Abstract][Full Text] [Related]
3. Non-syndromic Mitral Valve Dysplasia Mutation Changes the Force Resilience and Interaction of Human Filamin A.
Haataja TJK; Bernardi RC; Lecointe S; Capoulade R; Merot J; Pentikäinen U
Structure; 2019 Jan; 27(1):102-112.e4. PubMed ID: 30344108
[TBL] [Abstract][Full Text] [Related]
4. Emerging pathogenic mechanisms in human myxomatous mitral valve: lessons from past and novel data.
Hulin A; Deroanne C; Lambert C; Defraigne JO; Nusgens B; Radermecker M; Colige A
Cardiovasc Pathol; 2013; 22(4):245-50. PubMed ID: 23261354
[TBL] [Abstract][Full Text] [Related]
5. Stress-induced remodelling of the mitral valve: a model for leaflet thickening and superimposed tissue formation in mitral valve disease.
Kruithof BPT; Paardekooper L; Hiemstra YL; Goumans MJ; Palmen M; Delgado V; Klautz RJM; Ajmone Marsan N
Cardiovasc Res; 2020 Apr; 116(5):931-943. PubMed ID: 31497851
[TBL] [Abstract][Full Text] [Related]
6. Screening of TGFBR1, TGFBR2, and FLNA in familial mitral valve prolapse.
Aalberts JJ; van Tintelen JP; Oomen T; Bergman JE; Halley DJ; Jongbloed JD; Suurmeijer AJ; van den Berg MP
Am J Med Genet A; 2014 Jan; 164A(1):113-9. PubMed ID: 24243761
[TBL] [Abstract][Full Text] [Related]
7. Filamin-a-related myxomatous mitral valve dystrophy: genetic, echocardiographic and functional aspects.
Lardeux A; Kyndt F; Lecointe S; Marec HL; Merot J; Schott JJ; Le Tourneau T; Probst V
J Cardiovasc Transl Res; 2011 Dec; 4(6):748-56. PubMed ID: 21773876
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 pathway activation and adherens junction molecular pattern in nonsyndromic mitral valve prolapse.
Rizzo S; Basso C; Lazzarini E; Celeghin R; Paolin A; Gerosa G; Valente M; Thiene G; Pilichou K
Cardiovasc Pathol; 2015; 24(6):359-67. PubMed ID: 26345253
[TBL] [Abstract][Full Text] [Related]
10. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
11. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
Oyama MA; Elliott C; Loughran KA; Kossar AP; Castillero E; Levy RJ; Ferrari G
Cardiovasc Pathol; 2020; 46():107196. PubMed ID: 32006823
[TBL] [Abstract][Full Text] [Related]
12. Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.
Toomer K; Sauls K; Fulmer D; Guo L; Moore K; Glover J; Stairley R; Bischoff J; Levine RA; Norris RA
Anat Rec (Hoboken); 2019 Jan; 302(1):117-124. PubMed ID: 30288957
[TBL] [Abstract][Full Text] [Related]
13. Developmental basis for filamin-A-associated myxomatous mitral valve disease.
Sauls K; de Vlaming A; Harris BS; Williams K; Wessels A; Levine RA; Slaugenhaupt SA; Goodwin RL; Pavone LM; Merot J; Schott JJ; Le Tourneau T; Dix T; Jesinkey S; Feng Y; Walsh C; Zhou B; Baldwin S; Markwald RR; Norris RA
Cardiovasc Res; 2012 Oct; 96(1):109-19. PubMed ID: 22843703
[TBL] [Abstract][Full Text] [Related]
14. Human myxomatous mitral valve prolapse: role of bone morphogenetic protein 4 in valvular interstitial cell activation.
Sainger R; Grau JB; Branchetti E; Poggio P; Seefried WF; Field BC; Acker MA; Gorman RC; Gorman JH; Hargrove CW; Bavaria JE; Ferrari G
J Cell Physiol; 2012 Jun; 227(6):2595-604. PubMed ID: 22105615
[TBL] [Abstract][Full Text] [Related]
15. Critical Structural Defects Explain Filamin A Mutations Causing Mitral Valve Dysplasia.
Haataja TJK; Capoulade R; Lecointe S; Hellman M; Merot J; Permi P; Pentikäinen U
Biophys J; 2019 Oct; 117(8):1467-1475. PubMed ID: 31542223
[TBL] [Abstract][Full Text] [Related]
16. Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.
Mahimkar R; Nguyen A; Mann M; Yeh CC; Zhu BQ; Karliner JS; Lovett DH
Cardiovasc Pathol; 2009; 18(5):253-61. PubMed ID: 18835790
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Outcomes of Mitral Valve Repair for Leaflet Prolapse with Advanced versus Mild/Moderate Myxomatous Degeneration.
Guo Y; Song C; Wu X; Zheng X; Lu J; Fang X; Wang S; Huang X
Int Heart J; 2018 Nov; 59(6):1288-1295. PubMed ID: 30369571
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Echocardiographic Evaluation of an Unusual Presentation of X-Linked Myxomatous Valvular Dystrophy Caused by Filamin A Mutation.
Ma PH; Sachdeva R; Wilson EC; Guzzetta NA
Semin Cardiothorac Vasc Anesth; 2016 Sep; 20(3):240-5. PubMed ID: 27004951
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
[TBL] [Abstract][Full Text] [Related]
20. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
